PH3S107 - Design and Operation of Cleanrooms 01 Jan 2022 - 31 Aug 2028 | Version 1

Associated Module Information

Module Code: PH3S107
Module Title: Design and Operation of Cleanrooms
Faculty: Faculty of Computing, Engineering and Science
Faculty Group: Chemical and Environmental Sciences
Faculty Sub Group: Chemical and Environmental Sciences
Module Leader:
Module Team: Suzanna Kean
First Intended Intake: APR 2022 Final Year of Intake:
Date Closed:
Credit Value: 20 Credit Level: 6
Language: English
Percentage of Module Taught in Welsh: 0
Equivalent Module:
HECOS codes: 100144 - pharmaceutical engineering
HECOS Code Weighting: 100

Document Version Information

Version 1
Valid From 01 Jan 2022
Valid To 31 Aug 2028

Module Aims

The aim of this module is to give the students an understanding of the design and operation of cleanrooms to control contamination in a production setting, and the aseptic and sterile pharmaceutical manufacturing systems used in this environment. In addition, the module provides an understanding of the formulation goals and objectives for fill/finish sterile injectable drug products.

Content Summary

Indicative Syllabus:

• HVAC Requirements for Manufacture of Sterile Medicinal Products, and aseptic processing – Classified environments

• Area Classification Protection

• Working in a Cleanroom environment, and gowning requirements

•Setting formulation goals: physicochemical and biological properties

•Container closure systems and delivery systems for the administration of parenteral medication to patients

•Formulation additives, adjuvants and preservatives

This module is delivered through open/distance learning resource packs, pre-recorded lectures, problem-solving exercises and case studies.

Learning and Teaching Methods

Activity Type Hours
Independent Study 100
Directed Study 86
Formative Assessment - Independent 14
Total Hours Selected 200

Learning Outcomes

# Learning Outcome
LO1 Understand the fundamentals of Heating, Ventilation, and Air Conditioning (HVAC) design in the operation of cleanrooms
LO2 Determine suitable controlled environments for primary and secondary aseptic manufacturing, preventing cross-contamination from materials and personnel flows in Classified Environments and minimizing risks of microbiological contamination to the product, as well as particulate and pyrogen contamination, during aseptic processing
LO3 Determine the formulation goals for a parenteral sterile filled medication

Module Requisites

N/A

Assessment Criteria

Assessment Category Assessment Type Description Duration Word Count Weight (%) Best of? Pass Mark
Asynchronous Assessment Report 1 Assignment to address the design and operation of cleanrooms for the correct manufacture of medicinal products in an aseptic environment, and avoiding cross contamination to ensure product quality and patient safety. 0 4000 100 No 40

Assessment Matrix

Assessment Type Learning Outcomes
LO1 LO2 LO3
Report 1

Reading List

Open distance/learning pack of materials resources

EU GMP Annex-1, ‘Manufacture of Sterile Medicinal Products’, EUDRALEX Volume-4.

EU GMP Annex-2, ‘Manufacture of Biological Medicinal Products for Human Use’, EUDRALEX Volume-4.

FDA Pharmaceutical CGMPs Guidance for Industry, ‘Sterile Drug Products Produced by Aseptic Processing - Current Good Manufacturing Practice’.

Jeffery N. Odum (2004). ?Sterile Product Facility Design and Project Management. CRC Press, Boca Raton, Florida.

Bengt Ljungqvist & Berit Reinmuller (2002). ?Clean Room Design, Interpharm/CRC, Boca Raton.

ISPE Baseline Guide Volume-6 ? Biopharmaceuticals Manufacturing Facilities. (2004)